NRx Pharmaceuticals Inc (NASDAQ:NRXPW) — Market Cap & Net Worth
Market Cap & Net Worth: NRx Pharmaceuticals Inc (NRXPW)
NRx Pharmaceuticals Inc (NASDAQ:NRXPW) has a market capitalization of $141.94 ($141.94) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31775 globally and #6293 in its home market, demonstrating a 91.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NRx Pharmaceuticals Inc's stock price $0.01 by its total outstanding shares 9996 (10.00K). Review NRx Pharmaceuticals Inc (NRXPW) total liabilities to assess the company's total debt and financial obligations.
NRx Pharmaceuticals Inc Market Cap History: 2017 to 2026
NRx Pharmaceuticals Inc's market capitalization history from 2017 to 2026. Data shows change from $4.00K to $141.94 (-31.48% CAGR).
NRx Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NRx Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
NRx Pharmaceuticals Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $3.84K | $1.09 Million | $66.10K | 0.00x | 0.06x |
| 2019 | $1.73K | $1.21 Million | $408.43K | 0.00x | 0.00x |
| 2025 | $707.72 | $1.23 Million | -$28.62 Million | 0.00x | N/A |
Competitor Companies of NRXPW by Market Capitalization
Companies near NRx Pharmaceuticals Inc in the global market cap rankings as of June 18, 2026.
Key companies related to NRx Pharmaceuticals Inc by market ranking:
- Pyxis Tankers Inc (NASDAQ:PXSAW): Ranked #31766 globally with a market cap of $196.02 USD.
- Housing Development and Infrastructure Limited (NSE:HDIL): Ranked #31767 globally with a market cap of $193.44 USD ( Rs17.89K INR).
- PetroFrontier Corp (V:PFC): Ranked #31776 globally with a market cap of $136.55 USD ( CA$188.76 CAD).
- Tarrina Resources Limited (AU:TR8): Ranked #31777 globally with a market cap of $126.20 USD ( AU$178.35 AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #31766 | Pyxis Tankers Inc | NASDAQ:PXSAW | $196.02 | $0.02 |
| #31767 | Housing Development and Infrastructure Limited | NSE:HDIL | $193.44 | Rs1.80 |
| #31776 | PetroFrontier Corp | V:PFC | $136.55 | CA$0.02 |
| #31777 | Tarrina Resources Limited | AU:TR8 | $126.20 | AU$0.02 |
NRx Pharmaceuticals Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, NRx Pharmaceuticals Inc's market cap moved from $4.00K to $ 141.94, with a yearly change of -31.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $141.94 | -79.94% |
| 2025 | $707.72 | -44.69% |
| 2024 | $1.28K | -1.31% |
| 2023 | $1.30K | -48.14% |
| 2022 | $2.50K | -86.48% |
| 2021 | $18.49K | -60.64% |
| 2020 | $46.98K | +2608.93% |
| 2019 | $1.73K | -54.85% |
| 2018 | $3.84K | -3.92% |
| 2017 | $4.00K | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of NRx Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $141.94 USD |
| MoneyControl | $141.94 USD |
| MarketWatch | $141.94 USD |
| marketcap.company | $141.94 USD |
| Reuters | $141.94 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NRx Pharmaceuticals Inc
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone… Read more